Interferon-gamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis. 2007

Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
Department of Obstetrics and Gynecology, University of Greifswald, Wollweberstr. 1, 17475 Greifswald, Germany.

The subtle interaction between the implanting embryo and the maternal endometrium plays a pivotal role during the process of implantation. Human endometrial stromal cells (ESCs) express Fas and the implanting trophoblast cells secrete Fas ligand (FASLG, FasL), suggesting a possible role for Fas-mediated signaling during early implantation. Here we show that ESCs are primarily resistant to Fas-mediated apoptosis independently of their state of hormonal differentiation. Pre-treatment of ESCs with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha sensitizes them to become apoptotic upon stimulation of Fas by an agonistic anti-Fas antibody. Incubation of ESCs with the early embryonic signal human chorionic gonadotropin (hCG, CGB) does not influence their reaction to Fas stimulation. The sensitizing effect of IFN-gamma and TNF-alpha was accompanied by a significant upregulation of Fas and FLICE-inhibitory protein (FLIP, CFLAR) expression in ESCs. Additionally, we observed an activation of caspase 3, caspase 8 and caspase 9 upon apoptotic Fas triggering. In summary, we demonstrate that IFN-gamma and TNF-alpha sensitize primarily apoptosis-resistant ESCs to Fas-mediated cell death. This might be due to an upregulation of Fas expression, and apoptosis seems to be mediated by active caspase 3, caspase 8 and caspase 9. The observed pro-apoptotic effect of IFN-gamma and TNF-alpha on ESCs could play an important role in the modulation of early implantation.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003656 Decidua The hormone-responsive glandular layer of ENDOMETRIUM that sloughs off at each menstrual flow (decidua menstrualis) or at the termination of pregnancy. During pregnancy, the thickest part of the decidua forms the maternal portion of the PLACENTA, thus named decidua placentalis. The thin portion of the decidua covering the rest of the embryo is the decidua capsularis. Deciduum,Deciduas
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004717 Endometrium The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo. Endometria
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females

Related Publications

Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
December 1998, Endocrinology,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
January 2000, Clinical and experimental rheumatology,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
August 2014, Clinical & experimental ophthalmology,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
June 1997, Medical microbiology and immunology,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
December 1998, Experimental hematology,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
January 2000, Scandinavian journal of immunology,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
May 1996, Japanese journal of cancer research : Gann,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
August 1999, Zhonghua fu chan ke za zhi,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
September 1999, The Journal of laboratory and clinical medicine,
Herbert Fluhr, and Stefanie Krenzer, and Gerburg M Stein, and Björn Stork, and Margarita Deperschmidt, and Diethelm Wallwiener, and Sebastian Wesselborg, and Marek Zygmunt, and Peter Licht
August 2000, Cancer research,
Copied contents to your clipboard!